Liposarcoma: Multimodality Management and Future Targeted Therapies.
about
Systematic review of giant gastric lipomas reported since 1980 and report of two new cases in a review of 117110 esophagogastroduodenoscopies.Pictorial review of 18F-FDG PET/CT findings in musculoskeletal lesions.Preclinical evaluation of the Aurora kinase inhibitors AMG 900, AZD1152-HQPA, and MK-5108 on SW-872 and 93T449 human liposarcoma cells.Soft tissue tumors of the pelvis: Technical and histological considerations.Myxoid-round cell liposarcoma: MRI appearance after radiation therapy and relationship to response.Trabectedin arrests a doxorubicin-resistant PDGFRA-activated liposarcoma patient-derived orthotopic xenograft (PDOX) nude mouse model
P2860
Liposarcoma: Multimodality Management and Future Targeted Therapies.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Liposarcoma: Multimodality Management and Future Targeted Therapies.
@en
type
label
Liposarcoma: Multimodality Management and Future Targeted Therapies.
@en
prefLabel
Liposarcoma: Multimodality Management and Future Targeted Therapies.
@en
P2860
P1476
Liposarcoma: Multimodality Management and Future Targeted Therapies.
@en
P2093
Aimee M Crago
Mark A Dickson
P2860
P304
P356
10.1016/J.SOC.2016.05.007
P577
2016-07-30T00:00:00Z